Cheng S, Xu JX, Long WJ. Advances in the management of arteriosclerosis of the lower extremity: Integrating Western and Chinese medicine approaches. World J Clin Cases 2024; 12(36): 6871-6876 [DOI: 10.12998/wjcc.v12.i36.6871]
Corresponding Author of This Article
Wen-Jie Long, MD, PhD, Attending Doctor, Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 16 Jichang Road, Guangzhou 510006, Guangdong Province, China. derek1626@163.com
Research Domain of This Article
Chemistry, Physical
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Dec 26, 2024; 12(36): 6871-6876 Published online Dec 26, 2024. doi: 10.12998/wjcc.v12.i36.6871
Advances in the management of arteriosclerosis of the lower extremity: Integrating Western and Chinese medicine approaches
Sha Cheng, Jia-Xin Xu, Wen-Jie Long
Sha Cheng, Jia-Xin Xu, Department of Cardiovascular, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou 510000, Guangdong Province, China
Wen-Jie Long, Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, Guangdong Province, China
Co-first authors: Sha Cheng and Jia-Xin Xu.
Author contributions: Cheng S collected domestic and foreign literature, wrote the manuscript, conceived the structure of the article, organized the language of the article, clearly conveyed the author's point of view, and reflected on the depth and persuasiveness of the article; Xu JX made revisions and improvements to the article, including language polish, logical adjustments, and data updates; Long WJ was responsible for cutting-edge trends, selecting review topics , research hotspots, ensuring the article is innovative and timely, and conduct a final review of the article; all of the authors read and approved the final version of the manuscript to be published.
Supported byThe Scientific Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine, China, No. 2022ZYYJ01; and The Guangzhou Municipal Science and Technology Bureau's 2024 Basic and Applied Basic Research Topic, China, No. 2024A04J4254.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Jie Long, MD, PhD, Attending Doctor, Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 16 Jichang Road, Guangzhou 510006, Guangdong Province, China. derek1626@163.com
Received: July 19, 2024 Revised: August 29, 2024 Accepted: September 25, 2024 Published online: December 26, 2024 Processing time: 103 Days and 16.3 Hours
Abstract
This editorial provides a commentary on the recent article. The paper reviews current literature and explores innovative treatment strategies for lower extremity arteriosclerosis obliterans (LEASO) through an integrative approach. It highlights the effectiveness of combination therapies that merge traditional Chinese medicine (TCM) with Western medical practices, suggesting that such integrative methods may improve patient compliance and outcomes through personalized care. This paper stresses the importance of rigorous clinical trials to evaluate the efficacy and safety of TCM interventions within LEASO treatment protocols, advocating for evidence-based validation of these combined therapies. Our recommendations emphasize accurate diagnosis, appropriate pharmacological interventions, the use of advanced surgical and endovascular techniques, and the inclusion of TCM to address underlying dysfunctions. Additionally, continuous monitoring, patient education, and lifestyle modifications are essential to slow disease progression and achieve optimal patient outcomes. The paper concludes by calling for further research to develop standardized treatment protocols that effectively integrate both Western and Chinese medical approaches in managing LEASO.
Core Tip: Lower extremity arteriosclerosis obliterans (LEASO), a condition primarily influenced by smoking and diabetes, significantly increases the risks of limb ischemia and amputation. Current treatments, such as pharmacological and surgical interventions, provide limited relief. Integrative approaches that combine traditional Chinese medicine with Western medical practices offer holistic and personalized treatment strategy that focuses on addressing the root cause as well as managing symptoms. To establish the efficacy and safety of this combined approach, extensive randomized controlled trials are essential. Such evidence-based research is crucial for developing protocols that can improve patient outcomes in managing LEASO.
